A Phase 3 Randomized, Open-label, Multicenter Clinical Study of Bezuclastinib (CGT9486) and Sunitinib Versus Sunitinib in Patients with Gastrointestinal Stromal Tumors

Connective Tissue Oncology Society Annual Meeting

File size: 389.09 KB
Created: November 2022
Updated: October 2024
Hits: 28
Download Preview
Scroll to Top
Scroll to Top